Medtronic Launches the i-port Advance, An All-in-One Injection Port and Inserter

Medtronic has begun distribution of i-port Advance, the first device to combine an injection port and an inserter in one complete set. i-port Advance can be used for people on insulin injection therapy who want to administer insulin conveniently while eliminating the need to puncture the skin with each dose of medication. i-port Advance injection port is FDA approved and indicated for patients who administer multiple daily subcutaneous injections of physician prescribed medications, including insulin.

The i-port Advance is a small, circular, low profile device, about the size of a quarter, that stays on the skin like a bandage. Each i-port Advance can be used for three days, during which time the person with diabetes injects their insulin into the port instead of directly into the skin. With only one skin puncture every three days (when applying a new device) instead of multiple punctures each day, i-port Advance reduces bruising, pain and scar tissue while promoting healing. Each i-port Advance comes with a disposable serter (insertion aid) that provides nearly pain-free application of i-port to the skin. Because the device may remain in place for up to 72 hours, i-port Advance accommodates multiple drug injections without the discomfort of additional needle sticks

The i-port Advance may be used on a wide range of patients, including adults and children and is indicated for use with both insulin pens and syringes.

Healthcare professionals and people with diabetes interested in learning more about the product should contact Medtronic’s customer center at 800.646.4633 or online at www.i-port.com.